Major Objectives behind this Study:
# To define, describe, segment, and forecast the global Transfection Reagents Market on the basis of product, indication, end user, and region.
# To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and industry-specific challenges).
# To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market.
# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players.
# To forecast the size of the market, in five main regions (along with major countries)—North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
# To profile key players in the global market and comprehensively analyze their core competencies and market shares.
# To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global market.
Targeted Audience in This Study:
# Biopharmaceutical companies
# Biotechnology companies
# Transfection equipment, reagent, and kit manufacturing companies
# Suppliers and distributors of transfection reagents
# Research institutes
# Academic centers
# Venture capitalists
Find More Details | Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139141146
Factors Influencing Global Growth:-
Over the years, the transfection reagents and equipment market has witnessed various technological advancements to meet the needs of researchers and biotechnology & pharmaceutical companies. These advancements have led to the development of high throughput large scale transfection instruments and reagents with greater efficiency. Advanced technologies result in efficient quantitative and qualitative transfection in varied types of cells, including the hard-to-transfect cell lines.
Restraints:
# Selective Effectiveness of Transfection Reagents
# Home Brew Reagents Restrict Sale of Commercial Kits
# High Cost of Transfection Reagents
Opportunities:
# Large-Scale Transfections
# High-Growth Opportunities in Asian Market
Monetary Growth Expectations, Globally:
According to the Research Study conducted by MarketsandMarkets™: The global transfection reagent market includes forecast from 2016 to 2021. This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=139141146
Geographical Growth Scenario:
North America is expected to account for the largest share of the transfection reagent market, followed by Europe and Asia-Pacific. The largest share can be attributed to the increase in bio-based drug research, increase in demand for protein therapeutics, and increasing investment for development of biologics in the country. The Asia-Pacific transfection reagent market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.
Leading Market Players:
# Thermo Fisher Scientific Inc. (U.S.)
# Promega Corporation (U.S.)
# Hoffmann-La Roche Ltd. (Switzerland)
# QIAGEN N.V. (Netherlands)
# Polyplus-transfection SA (France)
# Bio-Rad Laboratories (U.S.) and many more…
Players operating in the transfection reagents and equipment market adopted strategies such as agreements, collaborations, and partnerships to strengthen their global presence.To Get Your Queries Resolved Regarding This Topic – Feel FREE to Connect to Our Research Experts
